欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1507/002
药品名称NOCDURNA
活性成分
    • Desmopressin acetate 50.0 µg
剂型Oral lyophilisate
上市许可持有人Ferring Läkemedel AB, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      NOCDURNA 50 Mikrogramm Lyophilisat zum Einnehmen
    • Denmark (DK)
      Nocdurna
    • Belgium (BE)
      Nocdurna 50 microgram lyophilisaat voor oraal gebruik
    • Netherlands (NL)
    • Luxembourg (LU)
      Nocdurna, 50 mcg, Lyophisilat oral
    • Iceland (IS)
      NOCDURNA 50 míkróg Frostþurrkuð tafla
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Portugal (PT)
    • Greece (GR)
      NOCDURNA
    • Norway (NO)
      Nocdurna
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Nokdirna 50 mikrogrami liofilizāts iekšķīgai lietošanai
    • Lithuania (LT)
      Nokdirna 50 mikrogramų geriamasis liofilizatas
    • Estonia (EE)
      NOKDIRNA
    • Cyprus (CY)
    • Romania (RO)
      NOCDURNA 50 micrograme liofilizat oral
许可日期2016/04/21
最近更新日期2025/01/28
药物ATC编码
    • H01BA02 desmopressin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase